🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of the study was to generate the data necessary to determine ...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-01
Trial ID
NCT01332305
Treatments Being Tested
Purpose of the study is to evaluate dose response relationship, efficacy, s...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-08
Trial ID
NCT00742209
Treatments Being Tested
This double-blind study will evaluate the pharmacokinetics of a single dose...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-08
Trial ID
NCT01476124
Treatments Being Tested
The primary objective of this trial is to assess the long-term safety and e...
Status
Completed
Location
Multiple Locations
Start Date
2006-06
Trial ID
NCT00333359
Treatments Being Tested
The primary objective of this trial is to assess the efficacy of XP13512 ta...
Status
Completed
Location
Multiple Locations
Start Date
2006-08
Trial ID
NCT00365352
Treatments Being Tested
This study was a multi center, randomized, double blind, active and placebo...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-04
Trial ID
NCT01332318
Treatments Being Tested
The purpose of this study is to determine whether gabapentin enacarbil (XP1...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-03
Trial ID
NCT00643760
Treatments Being Tested
The primary objective of this trial is to assess the efficacy of XP13512 ta...
Status
Completed
Location
Multiple Locations
Start Date
2006-03
Trial ID
NCT00298623
Treatments Being Tested
The purpose of this study is to determine whether gabapentin enacarbil (XP1...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-02
Trial ID
NCT00619476
Treatments Being Tested
The purpose of this study is to assess the efficacy and safety of GSK183826...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-10
Trial ID
NCT00748098
Treatments Being Tested